Tech Company M&A Transactions
Selexys Pharmaceuticals Acquisition
Selexys Pharmaceuticals was bought by Novartis AG. The transaction was announced on 11/21/2016. The transaction price was $665 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/21/2016
Transaction Type
M&A
Amount
$665,000,000
M&A Terms
Novartis (NOVN.S) is buying U.S.-based Selexys Pharmaceuticals in a deal worth up to $665 million, the Swiss drugmaker said on Monday, expanding its pipeline of medicines to combat blood diseases.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Research Parkway 510
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Rollins
Chief Medical Officer
Rodger McEver
Chief Scientific Officer
Richard Cummings
VP - Bus. Development
David Falconer
VP - Operations
Richard Alvarez
Browse more venture capital transactions:
Prev: 11/21/2016: Yup venture capital transaction
Next: 11/21/2016: Electric venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs